Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Prednisolone"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 24578
Tytuł:
Development and optimization of an in-house heterologous ELISA for detection of prednisolone drug in enzyme conjugates using spacers.
Autorzy:
Kumar D; Department of Reproductive Biomedicine, National Institute of Health and Family Welfare (NIHFW), New Delhi, India.; Quality Assurance Division, Food Safety and Standards Authority of India (FSSAI), New Delhi, India.
Oberoi HS; Quality Assurance Division, Food Safety and Standards Authority of India (FSSAI), New Delhi, India.
Singh H; Centre for Biomedical Engineering, Indian Institute of Technology Delhi (IIT-D), New Delhi, India.; Department of Biomedical Engineering, All India Institute of Medical Sciences Delhi (AIIMS-D), New Delhi, India.
Shrivastav TG; Department of Reproductive Biomedicine, National Institute of Health and Family Welfare (NIHFW), New Delhi, India.
Bhukya PL; Rodent Experimentation Facility, Indian Council of Medical Research (ICMR)-National Animal Resource Facility for Biomedical Research (Indian Council of Medical Research (ICMR)-NARFBR), Hyderabad, India.
Kumari M; Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth, Pune, India.
Koner BC; Multidisciplinary Research Unit, Maulana Azad Medical College and Associated Hospital, New Delhi, India.; Department of Biochemistry, Maulana Azad Medical College and Associated Hospital, New Delhi, India.
Sonkar SC; Multidisciplinary Research Unit, Maulana Azad Medical College and Associated Hospital, New Delhi, India.; Delhi School of Public Health, Institute of Eminence, University of Delhi, Delhi, India.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Aug 22; Vol. 14, pp. 1200328. Date of Electronic Publication: 2023 Aug 22 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies*
Prednisolone*
Humans ; Enzyme-Linked Immunosorbent Assay ; Immunoenzyme Techniques
Czasopismo naukowe
Szczegóły
Tytuł:
Basic clinical management of preschool wheeze.
Autorzy:
Bush A; Imperial College, London, UK.; National Heart and Lung Institute, London, UK.; Royal Brompton Harefield NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło:
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2023 Jul; Vol. 34 (7), pp. e13988.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Prednisolone*
Leukotriene Antagonists*/therapeutic use
Child ; Child, Preschool ; Humans ; Schools ; Respiratory Sounds/diagnosis ; Diagnosis, Differential
Czasopismo naukowe
Szczegóły
Tytuł:
Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial.
Autorzy:
Güler-Yüksel M; Department of Rheumatology and Immunology, Maasstad Hospital, Rotterdam, The Netherlands.
Kuijper M; Department of Rheumatology and Immunology, Maasstad Hospital, Rotterdam, The Netherlands.
Bos R; Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
Molenaar E; Department of Rheumatology, Groene Hart Hospital, Gouda, The Netherlands.
Emmering J; Department of Radiology and Nuclear Medicine, Maasstad Hospital, Rotterdam, The Netherlands.
Eshuis S; Department of Nuclear Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
Human A; Department of Nuclear Medicine, Groene Hart Hospital, Gouda, The Netherlands.
Reimann F; Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
Boers M; Department of Epidemiology & Data Science, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.
Kok MR; Department of Rheumatology and Immunology, Maasstad Hospital, Rotterdam, The Netherlands .
Pokaż więcej
Źródło:
RMD open [RMD Open] 2023 Jun; Vol. 9 (2).
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Prednisolone*/therapeutic use
Prednisolone*/adverse effects
Arthritis, Rheumatoid*/diagnosis
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/chemically induced
Humans ; Glucocorticoids ; Body Composition ; Body Weight
Czasopismo naukowe
Szczegóły
Tytuł:
Prednisolone pharmacokinetics after oral prednisone administration in paediatric patients with kidney transplant.
Autorzy:
de Truchis C; Service de Néphrologie Pédiatrique, CRMR MARHEA, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Bouazza N; EA 7323, Université Paris Cité, Pharmacologie et évaluations thérapeutiques chez l'enfant et la femme enceinte, Paris, France.; Unité de Recherche Clinique, Université de Paris Necker/Cochin, Hôpital Tarnier, Paris, France.; CIC-1419 Inserm, Cochin-Necker, Paris, France.
Foissac F; EA 7323, Université Paris Cité, Pharmacologie et évaluations thérapeutiques chez l'enfant et la femme enceinte, Paris, France.; Unité de Recherche Clinique, Université de Paris Necker/Cochin, Hôpital Tarnier, Paris, France.; CIC-1419 Inserm, Cochin-Necker, Paris, France.
Charbit M; Service de Néphrologie Pédiatrique, CRMR MARHEA, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Dehoux L; Service de Néphrologie Pédiatrique, CRMR MARHEA, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Lui G; EA 7323, Université Paris Cité, Pharmacologie et évaluations thérapeutiques chez l'enfant et la femme enceinte, Paris, France.; CIC-1419 Inserm, Cochin-Necker, Paris, France.; Service de Pharmacologie Clinique, Hôpital Cochin, AP-HP, Groupe Hospitalier Paris Centre, Paris, France.
Ribot M; Unité de Recherche Clinique, Université de Paris Necker/Cochin, Hôpital Tarnier, Paris, France.; Service de Pharmacologie Clinique, Hôpital Cochin, AP-HP, Groupe Hospitalier Paris Centre, Paris, France.
Briand N; Unité de Recherche Clinique, Université de Paris Necker/Cochin, Hôpital Tarnier, Paris, France.
Zheng Y; EA 7323, Université Paris Cité, Pharmacologie et évaluations thérapeutiques chez l'enfant et la femme enceinte, Paris, France.; Service de Pharmacologie Clinique, Hôpital Cochin, AP-HP, Groupe Hospitalier Paris Centre, Paris, France.
Tréluyer JM; EA 7323, Université Paris Cité, Pharmacologie et évaluations thérapeutiques chez l'enfant et la femme enceinte, Paris, France.; Unité de Recherche Clinique, Université de Paris Necker/Cochin, Hôpital Tarnier, Paris, France.; CIC-1419 Inserm, Cochin-Necker, Paris, France.; Service de Pharmacologie Clinique, Hôpital Cochin, AP-HP, Groupe Hospitalier Paris Centre, Paris, France.
Boyer O; Service de Néphrologie Pédiatrique, CRMR MARHEA, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Unité INSERM U1163, Institut Imagine, Paris, France.
Pokaż więcej
Źródło:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 May; Vol. 89 (5), pp. 1532-1540. Date of Electronic Publication: 2022 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Prednisolone*
Kidney Transplantation*/adverse effects
Humans ; Child ; Prednisone ; Cyclosporine/pharmacokinetics ; Immunosuppressive Agents ; Models, Biological
Czasopismo naukowe
Szczegóły
Tytuł:
Pemphigus foliaceus treated with minocycline monotherapy or low-dose prednisolone combination therapy.
Autorzy:
Fan B; Department of Dermatology, Peking University First Hospital, Beijing, P. R. China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, P. R. China.; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, P. R. China.
Chen X; Department of Dermatology, Peking University First Hospital, Beijing, P. R. China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, P. R. China.; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, P. R. China.
Zhu X; Department of Dermatology, Peking University First Hospital, Beijing, P. R. China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, P. R. China.; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, P. R. China.
Wang M; Department of Dermatology, Peking University First Hospital, Beijing, P. R. China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, P. R. China.; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, P. R. China.
Pokaż więcej
Źródło:
The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2113756. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:
Journal Article
MeSH Terms:
Prednisolone*/therapeutic use
Pemphigus*/drug therapy
Humans ; Minocycline/therapeutic use ; Glucocorticoids/therapeutic use ; Immunosuppressive Agents/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Single vs split dose of prednisolone in the treatment of relapses of childhood nephrotic syndrome.
Autorzy:
Weerasooriya WALK; Professorial Paediatric Unit, Teaching Hospital Peradeniya, Peradeniya, Sri Lanka.
Abeyagunawardena AS; Department of Paediatrics, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
Thalgahagoda RS; Department of Paediatrics, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka. .
Pokaż więcej
Źródło:
European journal of pediatrics [Eur J Pediatr] 2023 Apr; Vol. 182 (4), pp. 1741-1747. Date of Electronic Publication: 2023 Feb 09.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Prednisolone*/adverse effects
Nephrotic Syndrome*/drug therapy
Child ; Humans ; Infant ; Child, Preschool ; Adolescent ; Glucocorticoids/adverse effects ; Secondary Prevention/methods ; Recurrence ; Chronic Disease ; Treatment Outcome
Czasopismo naukowe
Szczegóły
Tytuł:
Targeting Glutaminolysis Shows Efficacy in Both Prednisolone-Sensitive and in Metabolically Rewired Prednisolone-Resistant B-Cell Childhood Acute Lymphoblastic Leukaemia Cells.
Autorzy:
Sbirkov Y; Department of Medical Biology, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria.; Research Institute at Medical University of Plovdiv (RIMU), 4000 Plovdiv, Bulgaria.
Vergov B; Department of Medical Biology, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria.
Dzharov V; Research Institute at Medical University of Plovdiv (RIMU), 4000 Plovdiv, Bulgaria.
Schenk T; Department of Hematology and Medical Oncology, Clinic of Internal Medicine II, Jena University Hospital, 07743 Jena, Germany.; Institute of Molecular Cell Biology, Jena University Hospital, 07745 Jena, Germany.
Petrie K; School of Medicine, Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland SR1 3SD, UK.
Sarafian V; Department of Medical Biology, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria.; Research Institute at Medical University of Plovdiv (RIMU), 4000 Plovdiv, Bulgaria.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Feb 08; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Prednisolone*/pharmacology
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Humans ; Child ; Glutamine/pharmacology ; Drug Resistance, Neoplasm/genetics ; Glucocorticoids/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Randomized control trial of prednisolone and doxycycline in patients with acute interstitial nephritis of unknown aetiology.
Autorzy:
Badurdeen Z; Centre for Education Research and Training On Kidney Diseases (CERTKiD), Faculty of Medicine, University of Peradeniya, Kandy, Sri Lanka. .
Ratnatunga N; Department of Pathology, Faculty of Medicine, University of Peradeniya, Kandy, Sri Lanka.
Abeysekera T; Renal Transplant and Dialysis Unit, Teaching Hospital, Kandy, Sri Lanka.
Wazil AWM; Renal Transplant and Dialysis Unit, Teaching Hospital, Kandy, Sri Lanka.
Rajakrishna PN; Renal Transplant and Dialysis Unit, Teaching Hospital, Kandy, Sri Lanka.
Thinnarachchi JP; Renal Transplant and Dialysis Unit, Teaching Hospital, Kandy, Sri Lanka.
Welagedera DD; Renal Transplant and Dialysis Unit, Teaching Hospital, Kandy, Sri Lanka.
Ratnayake N; Renal Transplant and Dialysis Unit, Teaching Hospital, Kandy, Sri Lanka.
Alwis APD; Renal Transplant and Dialysis Unit, Teaching Hospital, Kandy, Sri Lanka.
Abeysundara H; Department of Statistics and Computer Science, Faculty of Science, University of Peradeniya, Kandy, Sri Lanka.
Kumarasiri R; Department of Community Medicine, Faculty of Medicine, University of Peradeniya, Kandy, Sri Lanka.
Taylor R; School of Public Health and Community Medicine (SPHCM), Faculty of Medicine, University of New South Wales (UNSW), Kensington, Australia.
Nanayakkara N; Renal Transplant and Dialysis Unit, Teaching Hospital, Kandy, Sri Lanka.
Pokaż więcej
Źródło:
Trials [Trials] 2023 Jan 05; Vol. 24 (1), pp. 11. Date of Electronic Publication: 2023 Jan 05.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Doxycycline*/therapeutic use
Nephritis, Interstitial*/drug therapy
Prednisolone*/therapeutic use
Renal Insufficiency, Chronic*/drug therapy
Humans ; Glucocorticoids/therapeutic use ; Sri Lanka
SCR Disease Name:
Acute Tubulointerstitial Nephritis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prednisolone prescribing practices for dogs in Australia.
Autorzy:
Purcell B; Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, Victoria, Australia.
Wiethoelter A; Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, Victoria, Australia.
Dandrieux J; Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, Victoria, Australia.; Hospital for Small Animals, Royal (Dick) School of Veterinary Studies, College of Medicine and Veterinary Medicine, University of Edinburgh, Easter Bush, Midlothian, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Feb 28; Vol. 18 (2), pp. e0282440. Date of Electronic Publication: 2023 Feb 28 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Prednisolone*/therapeutic use
Immunosuppressive Agents*
Dogs ; Animals ; Australia ; Cytoskeleton ; Databases, Factual
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial.
Autorzy:
Othonos N; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.
Pofi R; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.; Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy.
Arvaniti A; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.; Department of Biological and Medical Sciences, Oxford Brookes University, Oxford, OX3 0BP, UK.
White S; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.
Bonaventura I; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.; Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy.
Nikolaou N; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.
Moolla A; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.
Marjot T; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.; Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Stimson RH; University/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, EH16 4TJ, UK.
van Beek AP; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
van Faassen M; Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Isidori AM; Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy.
Bateman E; Department of Immunology, Churchill Hospital, Oxford, OX3 7LE, UK.
Sadler R; Department of Immunology, Churchill Hospital, Oxford, OX3 7LE, UK.
Karpe F; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.
Stewart PM; Faculty of Medicine & Health, University of Leeds, Clarendon Way, Leeds, LS2 9NL, UK.
Webster C; Department of Pathology, University Hospitals Birmingham, NHS Foundation Trust, Birmingham, B15 2GW, UK.
Duffy J; Department of Pathology, University Hospitals Birmingham, NHS Foundation Trust, Birmingham, B15 2GW, UK.
Eastell R; Mellanby Centre for Musculoskeletal Research, Department of Oncology & Metabolism, Faculty of Medicine, Dentistry & Health, University of Sheffield, Sheffield, SR10 2RX, UK.
Gossiel F; Mellanby Centre for Musculoskeletal Research, Department of Oncology & Metabolism, Faculty of Medicine, Dentistry & Health, University of Sheffield, Sheffield, SR10 2RX, UK.
Cornfield T; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.
Hodson L; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.
Jane Escott K; Business Development & Licensing, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Whittaker A; Emerging Innovations Unit, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Kirik U; Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D AstraZeneca, Mölndal, Sweden.
Coleman RL; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.; Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, OX3 7LJ, UK.
Scott CAB; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.; Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, OX3 7LJ, UK.
Milton JE; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.; Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, OX3 7LJ, UK.
Agbaje O; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.; Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, OX3 7LJ, UK.
Holman RR; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK.; Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, OX3 7LJ, UK.
Tomlinson JW; Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE, UK. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2023 Feb 23; Vol. 14 (1), pp. 1025. Date of Electronic Publication: 2023 Feb 23.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
11-beta-Hydroxysteroid Dehydrogenase Type 1*/antagonists & inhibitors
Anti-Inflammatory Agents*/adverse effects
Prednisolone*/adverse effects
Humans ; Male ; Glucocorticoids/adverse effects ; Inflammation/drug therapy
Czasopismo naukowe
Szczegóły
Tytuł:
The anti-inflammatory effect of myrrh ethanolic extract in comparison with prednisolone on an autoimmune disease rat model induced by silicate.
Autorzy:
ElMosbah DE; Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt. .
Khattab MS; Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Emam SR; Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211, Egypt.
Miniawy HMFE; Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Pokaż więcej
Źródło:
Inflammopharmacology [Inflammopharmacology] 2022 Dec; Vol. 30 (6), pp. 2537-2546. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Journal Article
MeSH Terms:
Prednisolone*/pharmacology
Autoimmune Diseases*/chemically induced
Autoimmune Diseases*/drug therapy
Rats ; Animals ; Tumor Necrosis Factor-alpha ; Plant Extracts/therapeutic use ; Commiphora/chemistry ; Resins, Plant/pharmacology ; Anti-Inflammatory Agents/pharmacology ; Ethanol ; Silicates/pharmacology
Czasopismo naukowe
Szczegóły
Tytuł:
Belt-like rashes caused by systemic prednisolone acetate.
Autorzy:
Li A; Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Fang R; Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Sun Q; Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2022 Oct; Vol. 21 (10), pp. 5238-5240. Date of Electronic Publication: 2022 Jan 17.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Prednisolone*/therapeutic use
Humans ; Patch Tests
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of the Effects of 0.1% Fluorometholone and 1% Prednisolone on Intraocular Pressure and Schirmer Tear Test in Equine Eye.
Autorzy:
Atai T; Department of Clinical Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Ozmaie S; Department of Clinical Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran. Electronic address: z_.
Anoushepour A; Department of Clinical Sciences, Karaj Branch, Islamic Azad University, Tehran, Iran.
Pokaż więcej
Źródło:
Journal of equine veterinary science [J Equine Vet Sci] 2023 Sep; Vol. 128, pp. 104840. Date of Electronic Publication: 2023 Jun 21.
Typ publikacji:
Randomized Controlled Trial, Veterinary; Journal Article
MeSH Terms:
Intraocular Pressure*
Fluorometholone*/pharmacology
Fluorometholone*/therapeutic use
Horses ; Animals ; Female ; Prednisolone/pharmacology ; Prednisolone/therapeutic use ; Tears ; Ophthalmic Solutions/pharmacology
Czasopismo naukowe
Szczegóły
Tytuł:
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial.
Autorzy:
Hartman L; Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, the Netherlands; Department of Epidemiology & Data Science, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, the Netherlands. Electronic address: .
El Alili M; Department of Health Sciences, Amsterdam Public Health, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Cutolo M; Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy.
Opris D; Carol Davila University, Bucharest, Romania.
Da Silva J; Reumatologia, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Institute for Clinical and Biomedical Research (i.CBR), Faculty of Medicine, University of Coimbra, Portugal.
Szekanecz Z; Department of Rheumatology, Institute of Medicine, University of Debrecen Faculty of Medicine, Debrecen, Hungary.
Buttgereit F; Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Berlin, Germany.
Masaryk P; National Institute for the Rheumatic Diseases, Piešťany, Slovakia.
Bos R; Department of Rheumatology, Medical Center Leeuwarden, Leeuwarden, the Netherlands.
Kok MR; Department of Rheumatology and Clinical immunology, Maasstad Hospital, Rotterdam, the Netherlands.
Paolino S; Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy.
Coupé V; Department of Epidemiology & Data Science, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, the Netherlands.
Lems WF; Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, the Netherlands.
Boers M; Department of Epidemiology & Data Science, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, the Netherlands.
Pokaż więcej
Corporate Authors:
GLORIA consortium
Źródło:
Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2022 Dec; Vol. 57, pp. 152109. Date of Electronic Publication: 2022 Oct 21.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prednisolone*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Humans ; Cost-Benefit Analysis ; Quality-Adjusted Life Years ; Ethnicity
Czasopismo naukowe
Szczegóły
Tytuł:
Current and future treatment for alcoholic-related liver diseases.
Autorzy:
Yoon EL; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.; Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Republic of Korea.
Kim W; Department of Internal Medicine, Seoul National University College of Medicine and Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2023 Aug; Vol. 38 (8), pp. 1218-1226. Date of Electronic Publication: 2023 Jun 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hepatitis, Alcoholic*/diagnosis
Hepatitis, Alcoholic*/etiology
Hepatitis, Alcoholic*/therapy
Liver Diseases, Alcoholic*/etiology
Liver Diseases, Alcoholic*/therapy
Liver Diseases, Alcoholic*/diagnosis
Liver Transplantation*
Humans ; Prednisolone/therapeutic use ; Inflammation/drug therapy
Czasopismo naukowe
Szczegóły
Tytuł:
Perception and usage of short-term prednisone and prednisolone in dogs.
Autorzy:
Gober M; Zoetis LLC, 10 Sylvan Way, Parsippany, NJ, 07054, USA. .
Hillier A; Zoetis LLC, 10 Sylvan Way, Parsippany, NJ, 07054, USA.
Pokaż więcej
Źródło:
BMC veterinary research [BMC Vet Res] 2023 Jul 24; Vol. 19 (1), pp. 91. Date of Electronic Publication: 2023 Jul 24.
Typ publikacji:
Journal Article
MeSH Terms:
Drug-Related Side Effects and Adverse Reactions*/veterinary
Dog Diseases*
Dogs ; Animals ; Prednisolone ; Prednisone ; Polyuria/veterinary ; Hyperphagia ; Polydipsia/veterinary ; Perception
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Oral prednisolone suppresses skin inflammation in a healthy volunteer imiquimod challenge model.
Autorzy:
Assil S; Centre for Human Drug Research, Leiden, Netherlands.; Division of Biotherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands.
Buters TP; Centre for Human Drug Research, Leiden, Netherlands.; Leiden University Medical Centre, Leiden, Netherlands.; Department of Dermatology Erasmus Medical Centre, Rotterdam, Netherlands.
Hameeteman PW; Centre for Human Drug Research, Leiden, Netherlands.
Hallard C; Centre for Human Drug Research, Leiden, Netherlands.
Treijtel N; Centre for Human Drug Research, Leiden, Netherlands.
Niemeyer-Van der Kolk T; Centre for Human Drug Research, Leiden, Netherlands.
de Kam ML; Centre for Human Drug Research, Leiden, Netherlands.
Florencia EFIII; Department of Dermatology Erasmus Medical Centre, Rotterdam, Netherlands.
Prens EP; Department of Dermatology Erasmus Medical Centre, Rotterdam, Netherlands.
van Doorn MBA; Department of Dermatology Erasmus Medical Centre, Rotterdam, Netherlands.
Rissmann R; Centre for Human Drug Research, Leiden, Netherlands.; Division of Biotherapeutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands.; Leiden University Medical Centre, Leiden, Netherlands.
Klarenbeek NB; Centre for Human Drug Research, Leiden, Netherlands.; Leiden University Medical Centre, Leiden, Netherlands.
Jansen MAA; Centre for Human Drug Research, Leiden, Netherlands.
Moerland M; Centre for Human Drug Research, Leiden, Netherlands.; Leiden University Medical Centre, Leiden, Netherlands.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Jul 20; Vol. 14, pp. 1197650. Date of Electronic Publication: 2023 Jul 20 (Print Publication: 2023).
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Blister*
Dermatitis*
Humans ; Imiquimod/pharmacology ; Healthy Volunteers ; Prednisolone/pharmacology ; Prednisolone/therapeutic use ; Inflammation/chemically induced ; Inflammation/drug therapy ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Prolonged glucocorticoid administration affects oocyte morphology in cats (Felis catus) undergoing an ovarian stimulation protocol.
Autorzy:
Andrews CJ; Animal Science Group, School of Agriculture and Environment, Massey University, Private Bag 11-222, Palmerston North, 4442, New Zealand. Electronic address: .
Yapura J; School of Veterinary Science, Massey University, Private Bag 11-222, Palmerston North, 4442, New Zealand. Electronic address: .
Potter MA; Wildlife and Ecology Group, School of Natural Sciences, Massey University, Private Bag 11-222, Palmerston North, 4442, New Zealand. Electronic address: .
McGlade K; School of Veterinary Science, Massey University, Private Bag 11-222, Palmerston North, 4442, New Zealand. Electronic address: .
Thomas DG; Animal Science Group, School of Agriculture and Environment, Massey University, Private Bag 11-222, Palmerston North, 4442, New Zealand. Electronic address: .
Pokaż więcej
Źródło:
Theriogenology [Theriogenology] 2023 Sep 15; Vol. 208, pp. 77-87. Date of Electronic Publication: 2023 Jun 04.
Typ publikacji:
Journal Article
MeSH Terms:
Glucocorticoids*/pharmacology
Hydrocortisone*
Female ; Cats ; Animals ; Progesterone ; Oocytes ; Prednisolone/pharmacology ; Estradiol ; Glucose
Czasopismo naukowe
Szczegóły
Tytuł:
Demographics and treatment of patients with primary nephrotic syndrome in Japan using a national registry of clinical personal records.
Autorzy:
Nakagawa N; Division of Cardiology, Nephrology, Pulmonology and Neurology, Department of Internal Medicine, Asahikawa Medical University, 2-1-1-1 Midorigaoka-higashi, Asahikawa, Japan. .
Kimura T; Reverse Translational Research Project, Center for Rare Disease Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Japan.; Laboratory of Rare Disease Resource Library, Center for Rare Disease Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Japan.
Sakate R; Reverse Translational Research Project, Center for Rare Disease Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Japan.
Wada T; Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.; Department of Nephrology, Toranomon Hospital, Tokyo, Japan.
Furuichi K; Department of Nephrology, Kanazawa Medical University School of Medicine, Uchinada, Japan.
Okada H; Department of Nephrology, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
Isaka Y; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Narita I; Division of Clinical Nephrology and Rheumatology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 07; Vol. 13 (1), pp. 14771. Date of Electronic Publication: 2023 Sep 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Nephrotic Syndrome*/drug therapy
Nephrotic Syndrome*/epidemiology
Glomerulosclerosis, Focal Segmental*/drug therapy
Glomerulosclerosis, Focal Segmental*/epidemiology
Glomerulonephritis, Membranous*/drug therapy
Glomerulonephritis, Membranous*/epidemiology
Nephrosis, Lipoid*
Humans ; Japan/epidemiology ; Prednisolone ; Registries ; Demography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 24578

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies